Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Beckley Psytech is a biotechnology company developing psychedelic-based medicines for mental health conditions.
Cerevel Therapeutics is a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric disorders.
ConnectRN is a tech-enabled network built to improve clinicians' lives through access to community, opportunity, and support.
MedAvail focuses on the discovery, development, and commercialization of advanced nutrition products.
Aptinyx Inc. is a biopharmaceutical company.
CinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Calithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
Menlo Micro is the developer of the Ideal Switch, an electromechanical switch technology used to switch AC/DC and RF.
Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.
Scout Bi is a biotechnology company that specializes in veterinary, animal health, and gene therapy.
Pyramid Biosciences is a provider of biotechnological services.
Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.
CORXEL Pharmaceuticals is a biotechnology company that develops science and medicines for underserved patients.
Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.
Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.
Ambros Therapeutics is a clinical-stage biotechnology company.
Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.
Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.
Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies.
Cidara Therapeutics develops targeted immunotherapies aimed at improving treatment outcomes for patients with serious diseases.
Adage Capital Management has invested in 73 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Adage Capital Management's top investment sectors include Biotechnology, Therapeutics, Health Care, Medical, Life Science. The firm invests across 22 different industry categories.
Among tracked funding rounds, Kailera Therapeutics received $600.0M in a Series B round. Adage Capital Management's total known invested capital is $10.9B.
Adage Capital Management's average investment size is $148.9M across its portfolio of 73 companies.
Recent Adage Capital Management portfolio additions include Beckley Psytech, Cerevel Therapeutics, connectRN, MedAvail, Aptinyx. These companies were founded in 2020 or later.